Ajanta Pharma Limited Share Price & Stock Analysis

Ajanta Pharma Limited (NSE: AJANTPHARM, BSE: 532331) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹41,474 Cr, it ranks #232 by market cap among the 6,197 Indian listed companies on FinBizNet, and #3 of 63 in Pharmaceuticals. At ₹3,279.00 (as of 16 Nov 2026), the share price is 13.6% below its 52-week high of ₹3,796.00 and 34.1% above its 52-week low of ₹2,445.80. The share price is up 27.8% over one year and down 9.1% over three months.

Key Metrics

Current Price₹3,279.00
Market Cap₹41,474 Cr
NSE SymbolAJANTPHARM
BSE Code532331
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio39.4
Return on Equity25.39%
Return on Assets14.85%
52-Week Range₹2,445.80 – ₹3,796.00
1-Year Price Change+27.8%
3-Month Price Change-9.1%
Beta (1Y)0.19
Dividend Yield1.92%
HeadquartersMumbai, Maharashtra
Websitewww.ajantapharma.com

Latest Quarterly Results — Q2 FY27

Revenue₹1,794 Cr
Net Profit₹388 Cr
Net Margin21.6%
EPS (Basic)₹31.07
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Ajanta Pharma Limited Quarterly Revenue and Profit Trend

Ajanta Pharma Limited reported revenue of ₹1,794 Cr in Q2 FY27, up 32.5% from ₹1,354 Cr in Q2 FY26 and up 10.3% from ₹1,626 Cr in Q1 FY27. It posted a net profit of ₹388 Cr for the quarter, against a net profit of ₹260 Cr in Q2 FY26 (up 49.2%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹1,170 Cr (Q4 FY25) to ₹1,794 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹1,794 Cr₹388 Cr21.6%
Q1 FY27₹1,626 Cr₹334 Cr20.6%
Q4 FY26₹1,422 Cr₹267 Cr18.8%
Q3 FY26₹1,375 Cr₹274 Cr19.9%
Q2 FY26₹1,354 Cr₹260 Cr19.2%
Q1 FY26₹1,303 Cr₹255 Cr19.6%
Q4 FY25₹1,170 Cr₹225 Cr19.2%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 63.47% of Ajanta Pharma Limited's shares as of Sept 2026, against 66.25% in Sept 2025 (−2.78 percentage points). Delivery averaged 53.9% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Ajanta Pharma Limited

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic areas comprising cardiology, dermatology, ophthalmology, and pain management. The company operates in India, Africa, Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

Products and Services

1. Pharmaceuticals-This segment offers pharmaceutical and related products. 2. Pharmaceuticals-This segment offers pharmaceuticals and related products.

Ajanta Pharma Limited vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Astrazeneca Pharma India Ltd.₹16,078 Cr85.922.82%₹729 Cr-34.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Ajanta Pharma Limited?

Ajanta Pharma Limited is trading at ₹3,279.00, with a market capitalisation of ₹41,474 Cr.

Which sector does Ajanta Pharma Limited belong to?

Ajanta Pharma Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Ajanta Pharma Limited?

Ajanta Pharma Limited has a P/E of 39.4 and a return on equity of 25.39%.

What is the stock symbol of Ajanta Pharma Limited?

Ajanta Pharma Limited is listed on the NSE under the symbol AJANTPHARM and on the BSE under the scrip code 532331.

How has Ajanta Pharma Limited's share price moved over the past year?

Ajanta Pharma Limited's share price is up 27.8% over one year and down 9.1% over three months. Its 52-week range is ₹2,445.80 to ₹3,796.00.

What were Ajanta Pharma Limited's latest quarterly results?

In Q2 FY27, Ajanta Pharma Limited reported revenue of ₹1,794 Cr and net profit of ₹388 Cr, with basic EPS of ₹31.07 (consolidated, parsed from the company's exchange filing).

How have Ajanta Pharma Limited's revenue and profit changed over the past year?

Ajanta Pharma Limited reported revenue of ₹1,794 Cr in Q2 FY27, up 32.5% from ₹1,354 Cr in Q2 FY26 and up 10.3% from ₹1,626 Cr in Q1 FY27.

What is the promoter holding in Ajanta Pharma Limited?

Promoters held 63.47% of Ajanta Pharma Limited's shares as of Sept 2026, against 66.25% in Sept 2025 (−2.78 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.